Neurology Establishes Committee on Diversity and Inclusion
The Department of Neurology’s new Committee on Diversity and Inclusion convened for the first time on Friday, June 26, 2020. The committee’s purpose is to promote diversity within the department’s education, career development, and leadership initiatives.
Improving treatment for psychogenic seizures: “This is a group of patients that we are taking less seriously”
Tolchin designed a study - and is currently developing an app - using motivational interviewing (MI) as an intervention to improve treatment adherence in people with psychogenic non-epileptic seizures (PNES).Source: newswise
WHRY Funds Studies on Stroke, Endometrial Cancer, and Addiction to Opioids
Women’s Health Research at Yale today announced funding for three studies investigating sex differences in stroke, endometrial cancer, and alternate pain relief for women recovering from past opioid use who are giving birth via cesarean section.
Dr. David Hafler Conducts APSA Webinar
David Hafler MD recently served on the panel of a webinar led by the American Physician Scientists Association (APSA). The webinar presented strategies to support early-career residents, fellows, and junior faculty, as well as insights into how this group is affected by the COVID-19 pandemic.
NICU & Stroke Team to Present, Receive Awards at International Stroke Conference
Researchers at the Yale School of Medicine’s Neurointensive Care Unit (NICU) and Stroke division will present new, scientific findings and receive several major awards at the International Stroke Conference in Los Angeles from February 19 – 21, 2020.
The Departments of Anesthesiology and Neurology Host: “Perivascular Spaces in the Brain & Contributions to Pathology of Cerebral Small Vessel Disease” on March 24
The purpose of this Yale mini-symposium is to highlight the huge unmet clinical need to understand the pathophysiology of small vessel disease to inform future therapeutic efforts to reduce the burden of this illness due to cognitive impairment and dementia. In particular the cellular and molecular mechanisms that underlie diffuse white matter disease and small vessel disease in the brain, the relationships between them, and how they may contribute to cognitive impairment and dementia.
Weighing Cognitive Decline After Prostate Cancer Treatment
The October 17, 2019 Department of Internal Medicine’s inaugural The Second Century of Women at Yale: Emerging Leaders in Internal Medicine Medical Grand Rounds, “Cognitive Side Effects of Cancer Therapy,” was presented by Herta H. Chao, MD, PhD, associate professor of medicine (medical oncology).
Yale Receives Funding to Study Myasthenia Gravis
The National Institutes of Health through the Rare Diseases Clinical Research Consortia has awarded a research team from Yale University, George Washington University, and Duke University $7.8 million to establish a rare disease network for myasthenia gravis.
Yale Faculty Pioneer Development and Testing of Portable MRI Device
Yale researchers have agreed to develop, deploy, and test a new portable MRI scanner, a device its developer hopes will cost a fraction of that of traditional MRIs and make the new imaging technology available in clinics in the U.S. and around the world.
Brain Hemorrhage Surgery Boosts Survival, but Disability Risk Still High
While patients who undergo surgery for intracerebral hemorrhage (ICH) survive at higher rates than those who do not receive surgery, they are also at high risk of significant disability, according to a new Yale-led study published in the journal JAMA.
Yale Department of Neurology Receives Grant for Stroke Study
Yale’s Department of Neurology is one of seven medical institutions awarded $4 million from the National Institutes of Health to assess acute ischemic stroke treatments in rodent models. As a part of the Stroke Preclinical Assessment Network (SPAN), participating institutions will work together to increase the rigor surrounding testing for ischemic brain injury, taking a look at six neuroprotective therapies to improve outcomes after stroke.